BPTH — Bio Path Holdings Share News
0.000.00%
Last trade - 00:00Bio Path Holdings Inc reports results for the quarter ended in December - Earnings Summary
Brief: Bio-Path Holdings Reports Full Year 2022 Financial Results
Bio Path Holdings Inc expected to post a loss of 45 cents a share - Earnings Preview
Brief: Bio-Path Holdings Provides Clinical And Operational Update
Bio Path Holdings Inc expected to post a loss of 46 cents a share - Earnings Preview
Brief: Bio-Path Holdings Announces First Patient Dosed In Phase 1/1B Clinical Trial Of Bp1001-A In Solid Tumors
Bio Path Holdings Inc reports results for the quarter ended in September - Earnings Summary
Brief: Bio-Path Holdings Reports Third Quarter 2022 Financial Results
Bio Path Holdings Inc expected to post a loss of 45 cents a share - Earnings Preview
Bio Path Holdings Inc expected to post a loss of 45 cents a share - Earnings Preview
Brief: Bio-Path Holdings Announces First Patient Dosed In Phase 1/1B Study Of Bp1002 In Refractory/Relapsed Acute Myeloid Leukemia Patients
Bio Path Holdings Inc reports results for the quarter ended in June - Earnings Summary
Bio Path Holdings Inc expected to post a loss of 49 cents a share - Earnings Preview
Bio Path Holdings Inc expected to post a loss of 49 cents a share - Earnings Preview
Brief: Bio Path Holdings Inc Files For Mixed Shelf Of Up To $110 Million
U.S. RESEARCH ROUNDUP-Chevron, Lowe's Companies, TJX Companies
Bio Path Holdings Inc reports results for the quarter ended in March - Earnings Summary
Brief: Bio-Path Holdings Reports First Quarter 2022 Financial Results
Bio Path Holdings Inc expected to post a loss of 45 cents a share - Earnings Preview